CA2808164A1 - Prosthetic menisci and method of implanting in the human knee joint - Google Patents
Prosthetic menisci and method of implanting in the human knee joint Download PDFInfo
- Publication number
- CA2808164A1 CA2808164A1 CA2808164A CA2808164A CA2808164A1 CA 2808164 A1 CA2808164 A1 CA 2808164A1 CA 2808164 A CA2808164 A CA 2808164A CA 2808164 A CA2808164 A CA 2808164A CA 2808164 A1 CA2808164 A1 CA 2808164A1
- Authority
- CA
- Canada
- Prior art keywords
- menisci
- prosthetic
- meniscus
- prosthetic knee
- locating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000000629 knee joint Anatomy 0.000 title claims description 45
- 238000000034 method Methods 0.000 title claims description 45
- 210000003127 knee Anatomy 0.000 claims abstract description 128
- 239000000463 material Substances 0.000 claims abstract description 97
- 210000001179 synovial fluid Anatomy 0.000 claims abstract description 31
- 238000005461 lubrication Methods 0.000 claims abstract description 28
- 238000013519 translation Methods 0.000 claims abstract description 24
- 210000001188 articular cartilage Anatomy 0.000 claims abstract description 17
- 238000005304 joining Methods 0.000 claims abstract description 14
- 230000006378 damage Effects 0.000 claims abstract description 11
- 238000011161 development Methods 0.000 claims abstract description 10
- 201000008482 osteoarthritis Diseases 0.000 claims abstract description 6
- 230000000750 progressive effect Effects 0.000 claims abstract description 5
- 238000004873 anchoring Methods 0.000 claims abstract 3
- 230000005499 meniscus Effects 0.000 claims description 135
- 210000002303 tibia Anatomy 0.000 claims description 59
- 230000033001 locomotion Effects 0.000 claims description 34
- 210000004353 tibial menisci Anatomy 0.000 claims description 30
- 210000003041 ligament Anatomy 0.000 claims description 28
- 238000007493 shaping process Methods 0.000 claims description 26
- 210000001519 tissue Anatomy 0.000 claims description 23
- 210000000988 bone and bone Anatomy 0.000 claims description 20
- 238000006073 displacement reaction Methods 0.000 claims description 17
- 238000002513 implantation Methods 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 14
- 229920001184 polypeptide Polymers 0.000 claims description 13
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 13
- 230000002093 peripheral effect Effects 0.000 claims description 12
- 238000003491 array Methods 0.000 claims description 11
- 210000001264 anterior cruciate ligament Anatomy 0.000 claims description 10
- 229920001971 elastomer Polymers 0.000 claims description 10
- 239000000806 elastomer Substances 0.000 claims description 10
- 238000011068 loading method Methods 0.000 claims description 10
- 230000008439 repair process Effects 0.000 claims description 10
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 claims description 8
- 239000006261 foam material Substances 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 8
- 230000002787 reinforcement Effects 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 7
- 230000000295 complement effect Effects 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 7
- 210000000281 joint capsule Anatomy 0.000 claims description 7
- 239000002861 polymer material Substances 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 239000000788 chromium alloy Substances 0.000 claims description 6
- 238000004132 cross linking Methods 0.000 claims description 6
- 238000009826 distribution Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000956 alloy Substances 0.000 claims description 5
- 229920003235 aromatic polyamide Polymers 0.000 claims description 5
- 238000003780 insertion Methods 0.000 claims description 5
- 230000037431 insertion Effects 0.000 claims description 5
- 230000001050 lubricating effect Effects 0.000 claims description 5
- 229910001092 metal group alloy Inorganic materials 0.000 claims description 5
- 239000007769 metal material Substances 0.000 claims description 5
- 229920001296 polysiloxane Polymers 0.000 claims description 5
- 210000001258 synovial membrane Anatomy 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 4
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 4
- 125000000539 amino acid group Chemical group 0.000 claims description 4
- 239000002131 composite material Substances 0.000 claims description 4
- 239000000470 constituent Substances 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 229910052719 titanium Inorganic materials 0.000 claims description 4
- 239000010936 titanium Substances 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- 241000469816 Varus Species 0.000 claims description 3
- 239000004760 aramid Substances 0.000 claims description 3
- -1 benzoic peroxide Chemical class 0.000 claims description 3
- 239000013013 elastic material Substances 0.000 claims description 3
- 230000023597 hemostasis Effects 0.000 claims description 3
- 239000012779 reinforcing material Substances 0.000 claims description 3
- 229920002803 thermoplastic polyurethane Polymers 0.000 claims description 3
- 229910000838 Al alloy Inorganic materials 0.000 claims description 2
- 229910000952 Be alloy Inorganic materials 0.000 claims description 2
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 2
- 239000004433 Thermoplastic polyurethane Substances 0.000 claims description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 239000012300 argon atmosphere Substances 0.000 claims description 2
- 229910052790 beryllium Inorganic materials 0.000 claims description 2
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 claims description 2
- 230000005540 biological transmission Effects 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 239000013536 elastomeric material Substances 0.000 claims description 2
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims description 2
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 2
- 238000005470 impregnation Methods 0.000 claims description 2
- 238000009434 installation Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000000178 monomer Substances 0.000 claims description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 2
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 2
- 229910000623 nickel–chromium alloy Inorganic materials 0.000 claims description 2
- 229910052758 niobium Inorganic materials 0.000 claims description 2
- 239000010955 niobium Substances 0.000 claims description 2
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 claims description 2
- 229920001692 polycarbonate urethane Polymers 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- 239000003505 polymerization initiator Substances 0.000 claims description 2
- 229920003225 polyurethane elastomer Polymers 0.000 claims description 2
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 229920002994 synthetic fiber Polymers 0.000 claims description 2
- 229910052715 tantalum Inorganic materials 0.000 claims description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 2
- 239000011343 solid material Substances 0.000 claims 2
- 239000011521 glass Substances 0.000 claims 1
- 229910052755 nonmetal Inorganic materials 0.000 claims 1
- 238000004513 sizing Methods 0.000 claims 1
- 238000010276 construction Methods 0.000 abstract description 2
- 210000000689 upper leg Anatomy 0.000 description 27
- 239000010410 layer Substances 0.000 description 18
- 210000000845 cartilage Anatomy 0.000 description 16
- 230000014616 translation Effects 0.000 description 15
- 108010035532 Collagen Proteins 0.000 description 13
- 102000008186 Collagen Human genes 0.000 description 13
- 239000002775 capsule Substances 0.000 description 13
- 229920001436 collagen Polymers 0.000 description 13
- 210000004417 patella Anatomy 0.000 description 10
- 238000011084 recovery Methods 0.000 description 10
- 238000001356 surgical procedure Methods 0.000 description 10
- 108010067787 Proteoglycans Proteins 0.000 description 9
- 102000016611 Proteoglycans Human genes 0.000 description 9
- 210000004439 collateral ligament Anatomy 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 239000000314 lubricant Substances 0.000 description 8
- 210000002967 posterior cruciate ligament Anatomy 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 210000001503 joint Anatomy 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 210000002414 leg Anatomy 0.000 description 6
- 210000000426 patellar ligament Anatomy 0.000 description 6
- 230000035882 stress Effects 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- 230000002917 arthritic effect Effects 0.000 description 5
- 230000006866 deterioration Effects 0.000 description 5
- 238000013150 knee replacement Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000008093 supporting effect Effects 0.000 description 5
- 210000002435 tendon Anatomy 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 4
- 230000003412 degenerative effect Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 210000003052 knee medial collateral ligament Anatomy 0.000 description 4
- 230000037230 mobility Effects 0.000 description 4
- 229920001287 Chondroitin sulfate Polymers 0.000 description 3
- 229920000271 Kevlar® Polymers 0.000 description 3
- 102100028965 Proteoglycan 4 Human genes 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000002082 fibula Anatomy 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000004761 kevlar Substances 0.000 description 3
- 108010009030 lubricin Proteins 0.000 description 3
- 238000002595 magnetic resonance imaging Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000003387 muscular Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000000276 sedentary effect Effects 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 2
- DSUFPYCILZXJFF-UHFFFAOYSA-N 4-[[4-[[4-(pentoxycarbonylamino)cyclohexyl]methyl]cyclohexyl]carbamoyloxy]butyl n-[4-[[4-(butoxycarbonylamino)cyclohexyl]methyl]cyclohexyl]carbamate Chemical group C1CC(NC(=O)OCCCCC)CCC1CC1CCC(NC(=O)OCCCCOC(=O)NC2CCC(CC3CCC(CC3)NC(=O)OCCCC)CC2)CC1 DSUFPYCILZXJFF-UHFFFAOYSA-N 0.000 description 2
- 102000016284 Aggrecans Human genes 0.000 description 2
- 108010067219 Aggrecans Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 210000000838 condylus lateralis tibialis Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000005021 gait Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000004394 hip joint Anatomy 0.000 description 2
- 229940014041 hyaluronate Drugs 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 210000002463 superior tibiofibular joint Anatomy 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000003906 tibiofibular joint Anatomy 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N 2-Amino-2-Deoxy-Hexose Chemical compound NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 239000004970 Chain extender Substances 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010016228 Fasciitis Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 206010070670 Limb asymmetry Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 108010077465 Tropocollagen Proteins 0.000 description 1
- 241001227561 Valgus Species 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002745 epiphysis Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000000501 femur body Anatomy 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000000968 fibrocartilage Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 210000003918 fraction a Anatomy 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000000412 mechanoreceptor Anatomy 0.000 description 1
- 108091008704 mechanoreceptors Proteins 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 230000002126 nonhaemolytic effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 238000012829 orthopaedic surgery Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000037074 physically active Effects 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 210000003137 popliteal artery Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000000272 proprioceptive effect Effects 0.000 description 1
- 210000003314 quadriceps muscle Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011208 reinforced composite material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 230000003019 stabilising effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
- A61F2/3872—Meniscus for implantation between the natural bone surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30461—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30476—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements locked by an additional locking mechanism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/30971—Laminates, i.e. layered products
Landscapes
- Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010903553 | 2010-08-12 | ||
| AU2010903553A AU2010903553A0 (en) | 2010-08-12 | Prosthetic Menisci and Method of Implanting in the Human Knee Joint | |
| PCT/AU2011/001049 WO2012019248A1 (en) | 2010-08-12 | 2011-08-12 | Prosthetic menisci and method of implanting in the human knee joint |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2808164A1 true CA2808164A1 (en) | 2012-02-16 |
Family
ID=45567210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2808164A Abandoned CA2808164A1 (en) | 2010-08-12 | 2011-08-12 | Prosthetic menisci and method of implanting in the human knee joint |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20130144385A1 (OSRAM) |
| EP (1) | EP2603174A4 (OSRAM) |
| JP (1) | JP2013537451A (OSRAM) |
| CN (1) | CN103281990A (OSRAM) |
| AU (1) | AU2011288930A1 (OSRAM) |
| BR (1) | BR112013003327A2 (OSRAM) |
| CA (1) | CA2808164A1 (OSRAM) |
| RU (1) | RU2013110556A (OSRAM) |
| WO (1) | WO2012019248A1 (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014508555A (ja) * | 2010-12-21 | 2014-04-10 | プロストヘクシス ピーティワイ リミテッド | 人工半月およびヒトの膝関節に植え込む方法 |
| AU2012214106A1 (en) * | 2011-02-08 | 2013-09-26 | Prosthexis Pty Ltd | Prosthetic menisci and method of implanting in the human knee joint |
| WO2012159018A1 (en) * | 2011-05-18 | 2012-11-22 | Orteq Ltd. | Meniscus implant assembly and method |
| GB2517154A (en) | 2013-08-12 | 2015-02-18 | Biomet Uk Healthcare Ltd | Ligament assembly |
| WO2015135907A1 (en) * | 2014-03-11 | 2015-09-17 | Stichting Katholieke Universiteit, More Particularly Radboud Universiteit Nijmegen | Meniscus prosthesis |
| CN104352291A (zh) * | 2014-11-05 | 2015-02-18 | 上海大学 | 表面微织构型人工膝关节半月板 |
| KR102042646B1 (ko) * | 2016-10-06 | 2019-11-08 | 아주대학교산학협력단 | 반월상연골 후프 응력을 지지하는 디바이스 |
| CN107829123B (zh) * | 2017-10-09 | 2020-05-12 | 深圳市中科摩方科技有限公司 | 一种表面双层涂层的铝合金及其制备方法和应用 |
| US10827971B2 (en) | 2017-12-20 | 2020-11-10 | Howmedica Osteonics Corp. | Virtual ligament balancing |
| CN109620477B (zh) * | 2019-02-01 | 2024-04-02 | 北京爱康宜诚医疗器材有限公司 | 半月板替代物及具有其的膝关节假体 |
| CN110604635A (zh) * | 2019-09-27 | 2019-12-24 | 武汉德骼拜尔外科植入物有限公司 | 膝关节假体及其膝关节衬垫系统 |
| CN110934667A (zh) * | 2019-12-20 | 2020-03-31 | 王俊瑞 | 一种软骨保护垫 |
| CN112972070A (zh) * | 2021-02-04 | 2021-06-18 | 吉林大学 | 一种适用于骨关节炎患者的膝关节内侧半月板假体 |
| JPWO2023079768A1 (OSRAM) * | 2021-11-02 | 2023-05-11 | ||
| CN114758569B (zh) * | 2022-04-15 | 2024-04-30 | 武汉肤尔医用科技有限公司 | 可演示koapt运动中膝关节腔内压力变化的膝关节模型 |
| CN116999218B (zh) * | 2023-09-28 | 2023-12-22 | 北京爱康宜诚医疗器材有限公司 | 一种膝关节假体及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4502161A (en) * | 1981-09-21 | 1985-03-05 | Wall W H | Prosthetic meniscus for the repair of joints |
| US4919667A (en) * | 1988-12-02 | 1990-04-24 | Stryker Corporation | Implant |
| US5171322A (en) * | 1990-02-13 | 1992-12-15 | Kenny Charles H | Stabilized meniscus prosthesis |
| US5788625A (en) * | 1996-04-05 | 1998-08-04 | Depuy Orthopaedics, Inc. | Method of making reconstructive SIS structure for cartilaginous elements in situ |
| US6629997B2 (en) * | 2000-03-27 | 2003-10-07 | Kevin A. Mansmann | Meniscus-type implant with hydrogel surface reinforced by three-dimensional mesh |
| US9314339B2 (en) * | 2000-03-27 | 2016-04-19 | Formae, Inc. | Implants for replacing cartilage, with negatively-charged hydrogel surfaces and flexible matrix reinforcement |
| EP1315470B1 (en) * | 2000-08-28 | 2009-07-15 | Disc Dynamics, Inc. | System for mammalian joint resurfacing |
| US7572295B2 (en) * | 2001-12-04 | 2009-08-11 | Active Implants Corporation | Cushion bearing implants for load bearing applications |
| CA2473858A1 (en) * | 2002-01-22 | 2003-07-31 | Advanced Bio Surfaces, Inc. | Interpositional arthroplasty system and method |
| WO2005069957A2 (en) * | 2004-01-20 | 2005-08-04 | Alexander Michalow | Unicondylar knee implant |
| US8403985B2 (en) * | 2005-11-02 | 2013-03-26 | Zimmer, Inc. | Joint spacer implant |
| US8361147B2 (en) * | 2008-04-09 | 2013-01-29 | Active Implants Corporation | Meniscus prosthetic devices with anti-migration features |
| US8623085B2 (en) * | 2008-06-02 | 2014-01-07 | Rutgers, The State University Of New Jersey | Bioresorbable tissue engineered fibrocartilage replacement with three-dimensional matrix of fibers |
| EP2282786B1 (en) * | 2008-06-13 | 2015-10-28 | Smith & Nephew, Inc. | Fixation devices for tissue repair |
-
2011
- 2011-08-12 EP EP11815924.3A patent/EP2603174A4/en not_active Withdrawn
- 2011-08-12 JP JP2013523441A patent/JP2013537451A/ja not_active Withdrawn
- 2011-08-12 US US13/816,489 patent/US20130144385A1/en not_active Abandoned
- 2011-08-12 CA CA2808164A patent/CA2808164A1/en not_active Abandoned
- 2011-08-12 AU AU2011288930A patent/AU2011288930A1/en not_active Abandoned
- 2011-08-12 CN CN2011800493747A patent/CN103281990A/zh active Pending
- 2011-08-12 BR BR112013003327A patent/BR112013003327A2/pt not_active IP Right Cessation
- 2011-08-12 RU RU2013110556/14A patent/RU2013110556A/ru not_active Application Discontinuation
- 2011-08-12 WO PCT/AU2011/001049 patent/WO2012019248A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012019248A1 (en) | 2012-02-16 |
| CN103281990A (zh) | 2013-09-04 |
| RU2013110556A (ru) | 2014-09-20 |
| AU2011288930A1 (en) | 2013-03-28 |
| EP2603174A4 (en) | 2014-09-17 |
| US20130144385A1 (en) | 2013-06-06 |
| BR112013003327A2 (pt) | 2016-07-05 |
| JP2013537451A (ja) | 2013-10-03 |
| EP2603174A1 (en) | 2013-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20130144385A1 (en) | Prosthetic menisci and method of implanting in the human knee joint | |
| US20130268074A1 (en) | Prosthetic menisci and method of implanting in the human knee joint | |
| EP1742597B1 (en) | Surgically implantable knee prosthesis | |
| US10092405B2 (en) | Method of treating a patient's joint using a resilient arthroplasty device | |
| US8287594B2 (en) | Knee joint prosthesis and hyaluronate compositions for treatment of osteoarthritis | |
| US6994730B2 (en) | Meniscal and tibial implants | |
| US7819919B2 (en) | Surgically implantable knee prosthesis | |
| JP2020039913A (ja) | 関節スペーサー | |
| US20130312897A1 (en) | Prosthetic menisci and method of implanting in the human knee joint | |
| JP5753075B2 (ja) | 半月板の人工器官及びこれに関連する方法 | |
| JPS5848180B2 (ja) | 改良補綴関節 | |
| JP2013537451A5 (OSRAM) | ||
| JP2013538087A (ja) | 股関節への負荷を制御するための装置 | |
| CN221060964U (zh) | 定制个体化半髁假体 | |
| AU2011349045A1 (en) | Prosthetic menisci and method of implanting in the human knee joint | |
| Das et al. | Biotribology Study of Knee Replacement: A Review |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20160812 |